Life sciences is too important to let promising innovation stall because the business side was underbuilt. Fractional ...

Cyber insurance has been around for a while, but it’s evolving quickly. Here’s why life sciences are so attractive — and how ...

Wave plans to initiate the Phase IIa multiple-dose portion of the INLIGHT trial this quarter, targeting participants with ...

Any AI tool. Any data source. Governed from the first query. Industrial teams want to use the best AI tools on their ...

US law firms highlight litigation profitability and client demand as driving forces behind a boom in lateral hires in the ...

For pharmaceutical and life sciences companies ready to embrace this moment, the 10 principles aren't a burden. They're a ...

Q1 2026 earnings call highlights: guidance reaffirmed, AI rollout traction, China momentum, IP rebound outlook, and LS&H sale ...

Angel investors are raising the bar with tighter criteria, backing strong teams, realistic markets and clear paths to exit ...

Based on public information as of May 2026, Professor Yang Yongzhong (Director of the Institute of Creative Management, ...

Life Sciences' $400 million commitment to Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) in March could be an example.

The University of Wyoming College of Agriculture, Life Sciences and Natural Resources recognized outstanding educators and staff members at its recent annual awards banquet.

Q1 2026 earnings call recap: guidance cut on Middle East headwinds, ddPCR/QX700 momentum, margins & FCF outlook—read key takeaways.